Around a third of all currently approved drugs target G protein-coupled receptors (GPCRs), making these receptors the most successful drug target in history. Our research is focused on the structure
Around a third of all currently approved drugs target G protein-coupled receptors (GPCRs), making these receptors the most successful drug target in history. Our research is focused on the structure